EUVIMEDEUVIMED entdecken
Crossref

Dual-targeting ferritin nanocages potentiate betulinic acid therapy against metastatic melanoma

Yuan Fan, Lele Yu, Han Chen, Kaichen He, Liujiao Wang, Junyu Xia, Fuxue Chen, Shini Feng

Chemical Engineering Journal · 2026-11 · 548 · 182177

DOI: 10.1016/j.cej.2026.182177 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Engineering Journal, 2026-11. Verfasst von Yuan Fan und 7 weiteren Autor:innen. Die Arbeit nennt 59 Literaturangaben. Gefördert von: Natural Science Foundation of Shanghai Municipality.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • Natural Science Foundation of Shanghai Municipality

Zitieren

APA

Fan, Y., Yu, L., Chen, H., He, K., Wang, L., Xia, J., Chen, F., & Feng, S. (2026). Dual-targeting ferritin nanocages potentiate betulinic acid therapy against metastatic melanoma. Chemical Engineering Journal, 548, 182177. https://doi.org/10.1016/j.cej.2026.182177

Vancouver

Fan Y, Yu L, Chen H, He K, Wang L, Xia J, et al. Dual-targeting ferritin nanocages potentiate betulinic acid therapy against metastatic melanoma. Chemical Engineering Journal. 2026;548:182177. doi:10.1016/j.cej.2026.182177

BibTeX
@article{Fan2026,
  author = {Fan, Yuan and Yu, Lele and Chen, Han and He, Kaichen and Wang, Liujiao and Xia, Junyu and Chen, Fuxue and Feng, Shini},
  title = {Dual-targeting ferritin nanocages potentiate betulinic acid therapy against metastatic melanoma},
  journal = {Chemical Engineering Journal},
  year = {2026},
  volume = {548},
  pages = {182177},
  doi = {10.1016/j.cej.2026.182177}
}
Kostenlos starten →